NanoViricides, Inc. NNVC
1.44
0.00
0.00%
as of 25 Sep
- Market cap
- $38.0M
- P/E
- 0.0×
Follow NNVC
| Mar '26 | Dec '25 | Sep '25 | Jun '25 | Older periods | |
|---|---|---|---|---|---|
Current Ratio |
3.17 | 4.43 | 1.06 | 1.28 |
+8 more quarters Free account |
Net Debt/EBITDA |
1.69 | 2.45 | 0.68 | 0.80 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.97 | 0.92 | 0.89 | 0.81 | |
Capex/Depreciation |
0.00 | 0.00 | (0.63) | (0.06) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.03 | 0.03 | 0.04 | 0.04 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow per Share |
(0.09) | (0.10) | (0.10) | (0.11) | |
Cash per Share |
0.15 | 0.26 | 0.07 | 0.10 | |
Shareholders Equity per Share |
0.42 | 0.56 | 0.42 | 0.50 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.42 | 0.56 | 0.42 | 0.50 | |
Free Cash Flow |
(1.93) | (2.05) | (1.68) | (1.71) | |
Working Capital |
2.31 | 4.10 | 0.07 | 0.36 | |
Capital Expenditures |
0.00 | 0.00 | (0.08) | (0.01) | |
Net Current Asset Value |
2.31 | 4.10 | 0.07 | 0.36 | |
| Other line items | |||||
Quick Ratio |
3.02 | 4.31 | 0.95 | 1.19 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.09) | (0.10) | (0.09) | (0.11) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Payables |
1.10 | 1.13 | 1.25 | 1.19 | |
Average Assets |
10.13 | 11.92 | 10.05 | 10.82 | |
Average Common Equity |
8.99 | 10.73 | 8.64 | 9.49 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates